Home › Trial NCT00921258
Active Control of Prostatic Cancer With Criteria of Latence
- Trial IDNCT00921258
- StatusTerminated
- PhaseN/A
- Study typeObservational
- SponsorClinique Mutualiste Chirurgicale de la Loire
- Enrollment100
- Start date2007-12
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.